drugset / Trial / NCT01165983

The Effect of Aliskiren on Endothelial Function in Pre-Diabetes and Diabetes

NCT01165983

RandomizedParallel-groupDouble-blindBasic science

Summary

The purpose of this research is to study and determine the effects of Aliskiren on blood vessels and blood flow. The primary hypothesis is that Aliskiren will increase endothelial function by 30% or more in comparison to the placebo group.

Timeline

Start
2009-11
Primary completion
2012-01
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Aliskiren Small molecule 150 mg Oral